admin • September 21, 2023
Educate and Advocate

By Dawn Levitt – https://dawnlevittauthor.com/

My experience with the medical system began when I was a young child running around like most little kids do, but I became very short of breath and tired after a brief bit of exercise.  My pediatrician diagnosed me with asthma and gave me an inhaler. 

When I was seven years old, I collapsed while running laps in gym class.   This was the 1970’s and I was sent to the principal’s office to wait for my mother to pick me up.  She didn’t think anything of it because I had been a sickly child all my life, but my grandmother pushed for me to see the pediatrician.  He detected a heart murmur and referred me to the Children’s Hospital of Detroit.

At the Children’s Hospital of Detroit, I was diagnosed with Idiopathic Hypertrophic Subaortic Stenosis (IHSS).  This would later be classified as Hypertrophic Cardiomyopathy (HCM).  As a child, I had no idea what that meant and neither did my mother.  I was given beta-blockers and had to return once every summer for checkups.

At the age of 16, I was transferred to the care of a new cardiology practice opening in our small town.  This new doctor never talked to me, the patient, but spoke with my mother.  She didn’t understand most of what he told her, only telling me that I was not expected to live past the age of thirty years.

When I became an adult, I continued to see the same cardiologist who told my mother of my “expiration date” because he was the only cardiologist in town.   Growing up with a heart condition, I had become used to regular doctor visits and always following doctor’s orders, so I never thought to question anything he said.

When I turned thirty and didn’t die, I began to think that the doctor might be wrong.  My symptoms worsened, even with beta blockers and antiarrhythmic drugs, and the same cardiologist suggested I might need a pacemaker.  Due to my absolute lack of understanding of my condition, I thought he was suggesting open heart surgery and balked at the idea.  He referred me to another cardiologist at a larger practice who might be better equipped to help me.

This new cardiologist swapped some of my meds for a different combination and told me I didn’t need a pacemaker.  But he never gave me any further information about my condition, and I never thought to ask.  At my last appointment with him, he was not concerned about my worsening symptoms.

During that appointment, I told him about a recent business trip where I ran through the airport to catch my flight.  During that run, I felt light-headed and like I was going to pass out.  This was not a feeling I had experienced before.  He asked if I felt any shortness of breath climbing stairs, and I told him that I did not.  He was not concerned about the airport episode, instead noting that I had gained eight pounds since my last visit six months earlier.

“I think you would feel better if you lost ten pounds,” he told me.  That was it.  There was no echocardiogram, no blood work, no outpatient heart monitor.  The nurse took my blood pressure and the doctor listened to my heart for thirty seconds. 

Several weeks later, I came down with what I thought was the flu.  It was the Christmas holiday weekend, and I went to the urgent care nearest my home.  The doctor on duty confirmed the flu and prescribed Tamiflu.  After Christmas, I followed up with my primary care physician because my cough had worsened.  He diagnosed bronchitis.  I returned to work after the New Year’s holiday, but I kept getting sicker, developing a worsening shortness of breath.  This time, my primary care physician diagnosed pneumonia.

Two days later, I went to the emergency department at the hospital because I had reached the point that I could not breathe lying flat and even sitting up in the recliner to sleep had me struggling to draw a breath.  I felt like I was drowning in dry air and began to panic.

It was the doctor at the emergency department who accurately diagnosed me with Congestive Heart Failure (CHF) and admitted me for treatment.  After five days of receiving diuretics, several liters of fluid were removed from my body, and I could breathe freely again.

Even at this point, my understanding of my heart condition was sorely lacking.  I falsely believed that the fluid removal had cured me.  Unfortunately, I learned very quickly that the fluid was only one symptom of my underlying condition.

During this hospital admission, my original cardiologist came to my bedside.  He was not surprised by the sudden failure of my heart, and he said the words I will never forget.

“This is the normal progression of your disease.  Your heart will grow weaker until it stops.  There is nothing more we can do for you.”

This was January of 2004, and the internet was still in its infancy.  I read everything I could find about my heart condition and joined Yahoo Groups dedicated to CHF.  One of the people I met online gave me the advice that saved my life.  She told me to go to the Cleveland Clinic for a second opinion.

It was a stroke of luck that I was able to get an appointment at the Cleveland Clinic and it was there that I received an accurate diagnosis and a thorough plan of care.  Just as important, they educated me on my condition and how to care for myself.  They were the first medical providers to suggest a heart transplant for my condition.

I still had a long road ahead of me, but I had learned about my condition and how to advocate for myself.  Without this, I would not be alive today.  Always ask questions and push for answers.   Don’t be afraid to seek a second opinion. 

HCMA Blog

April 15, 2025
It is hard to believe the first quarter of 2025 is in the history books. In the space of hypertrophic cardiomyopathy and thick heart muscle disorders, the distance between the promise and the delivery of a reality freed from burden of disease is closer than it has ever been, not only in the United States but throughout the world. Unfortunately, we are navigating through some challenging health policy times, which will impact a large percentage of those with the diseases we seek to serve. While we navigate these challenging waters together, we remain committed to ensuring safe, accessible, affordable, healthcare while ensuring the rights of those with disabilities are maintained. Last month, I attended two large conferences - one held in Stockholm, Sweden the other Chicago, Illinois. The research communities worldwide are holding their breath, waiting to see how we will move forward, even as we continue to develop new therapies, treatments and, even potentially, cures. It has never been more important to keep research moving, as we are so close to so many amazing improvements in our ability to care for those with thick heart muscle disorders, including HCM in all its forms, Amyloidosis, Fabry’s disease, Danon disease, and RASopathies. There was amazing science presented at the American College of Cardiology, where we warmly welcomed new president, Dr Christopher Kramer, the original director of the hypertrophic cardiomyopathy center at University of Virginia. We look forward to his leadership and wish him well in his challenging tasks ahead. Later this month we will be in Orlando Florida - please register and join us for this wonderful Bighearted warrior tour in person with our friends at AdventHealth and the incomparable Dr. Marcos Hazday. I even understand that there's some carpooling being organized from the Tampa area. If you're interested, reach out to the office and we will connect you. Maybe, the most impactful thing that will happen in the month of April is that we will conduct our second visit to Capitol Hill. Our lead topic this year is something you have heard us talk about at many prior meetings of the HCMA and podcasts; the generic drug quality issue. We are proud to be partnering with David Light, Co-founder and President of Valisure, and retired Colonel Vic Suarez, to ask House and Senate members to support the inspection of all generic drugs purchased by the Department of Defense and the Veterans Administration and make results of these inspections open for public use. Secondly, we are seeking rational oversight of health insurance companies’ abuse of prior authorizations and step therapy requirements. These issues cost an estimated 1.3 billion dollars a year and provide nothing to keep a patient safer or a physician's office running more efficiently. Common sense tells us to not waste money where there is no return. Additionally, prior authorizations and step therapies can keep patients sicker longer, ultimately costing the healthcare system more money. Our briefing will educate Representatives to act in an informed manner when moving policies that impact us all. You can watch us live at our briefing Wednesday April 9th 5:00 to 7:00 p.m. on Vimeo: https://vimeo.com/event/5043266 If you wish to get involved or more informed on any of the issues above, I encourage you to visit the website, 4hcm.org , or reach out to the office and the staff will be happy to assist you. On the day before I head out to Washington DC, I will leave you with this one thought - we have come a really long way in our understanding of HCM over the past 60 years. We have increased the lifespan of those with HCM, through collaborative research and implementation of best practices in an organized fashion throughout this country. We have worked so hard to end suffering for so many, and we are succeeding in our shared goal to outsmart hypertrophic cardiomyopathy and other thick heart muscle disorders. It is important to continue the research into all aspects of these diseases, including the biological, the clinical, burden of disease measurements. System improvements, positive impact of timely diagnosis and treatment, and the value to society of all of these big hearts being here, keeping their families whole. So we're off to DC to try to educate others about what it really means to live in our ecosystem. Best wishes, Lisa
Three colored chevrons create a decision flowchart: Identification, Analysis, Evaluation.
By Gordon Fox April 14, 2025
This first in a series post about making decisions as you navigate living with HCM, focuses on the three steps of decision-making: Identification, Analysis, Evaluation.
March 24, 2025
Who should have genetic testing, and when?
More Posts